Abstract
Elevated CSF free kappa light chains (FKLCs) may predict disability in multiple sclerosis (MS). We reviewed records of 57 patients with MS with 15-year median follow-up for correlations of disability and CSF FKLCs. Levels > or = 1.53 microg/mL predicted progression to need for ambulatory assistance during follow-up (specificity 87.5%, positive predictive value 88.9%) or within 10 years (specificity 78.6%, positive predictive value 66.7%).
Publication types
-
Clinical Trial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Biomarkers / cerebrospinal fluid
-
Cohort Studies
-
Disability Evaluation*
-
Female
-
Health Status Indicators*
-
Humans
-
Immunoglobulin kappa-Chains / cerebrospinal fluid*
-
Male
-
Multiple Sclerosis / cerebrospinal fluid*
-
Multiple Sclerosis / diagnosis*
-
Prognosis
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Statistics as Topic
Substances
-
Biomarkers
-
Immunoglobulin kappa-Chains